CORMEDIX INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
CORMEDIX INC. (CRMD) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $7.26 per share as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2023-03-30
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $7.26.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $8.04.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $8.20.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $8.34.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-12-31 | $7.26 10-K · filed 2023-03-30 |
| 2021-12-31 | $8.04 10-K · filed 2022-03-29 |
| 2021-06-30 | $8.20 10-Q · filed 2021-08-12 |
| 2021-03-31 | $8.34 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.56 10-K · filed 2021-03-30 |
| 2020-09-30 | $8.53 10-Q · filed 2020-11-05 |
| 2020-06-30 | $8.62 10-Q · filed 2020-08-10 |
| 2020-03-31 | $8.94 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.31 10-K · filed 2020-03-16 |
| 2019-09-30 | $9.16 10-Q · filed 2019-11-14 |
| 2019-06-30 | $9.18 10-Q · filed 2019-08-14 |
| 2019-03-31 | $9.30 10-Q · filed 2019-05-13 |
| 2018-12-31 | $1.88 10-K · filed 2019-05-29 |
| 2018-09-30 | $1.80 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.86 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.89 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.17 10-K · filed 2018-03-19 |
| 2017-09-30 | $1.82 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.08 10-Q · filed 2017-08-09 |
| 2017-03-31 | $2.10 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.13 10-K · filed 2017-03-16 |
| 2014-12-31 | $1.25 10-K · filed 2015-03-12 |
| 2014-03-31 | $1.08 10-Q · filed 2014-05-15 |
| 2013-12-31 | $0.90 10-K · filed 2015-03-12 |
| 2013-09-30 | $0.81 10-Q/A · filed 2014-03-04 |
| 2013-06-30 | $0.78 10-Q/A · filed 2014-03-04 |
| 2013-03-31 | $0.78 10-Q · filed 2014-05-15 |
| 2012-12-31 | $1.26 10-K · filed 2014-03-31 |
| 2012-09-30 | $1.82 10-Q/A · filed 2014-03-04 |
| 2012-06-30 | $2.10 10-Q/A · filed 2014-03-04 |
| 2011-12-31 | $2.47 10-K/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |